Dublin, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The "Companion Animal Pharmaceuticals Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. The Companion Animal ...
(MENAFN- GlobeNewsWire - Nasdaq) Key opportunities in the companion animal pharmaceuticals market include developing advanced biologics and targeted therapies driven by increased pet ownership and ...
Novel Delivery System for High-Molecular-Weight Collagen Advances Anti-Aging Science at the Society of Cosmetic Chemists' ...
Smithsonian Magazine on MSN
The High-Stakes Quest to Make Snakebites Survivable Took Leaps Forward This Year, With Promising New Avenues to Safer Antivenoms
A wave of fresh science is challenging a century-old treatment and offering hope to the people snakebites harm most—often far ...
New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidenceWALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world ...
Hosted on MSN
What happened to Shigeta Animal Pharmaceuticals?
Shigeta Animal Pharmaceuticals, established in 1984 in Toyama Prefecture, was notable for developing the first canine/feline blood-group testing kit utilizing monoclonal-antibody technology. In 2004, ...
In April 2025, the U.S. Food and Drug Administration (FDA) released its Roadmap to Reducing Animal Testing in Preclinical Safety Studies—a landmark initiative that lays out a plan to make animal ...
Just The News on MSN
Senate unanimously approves bill to 'replace outdated animal testing,' still awaiting House
"For too long, bureaucratic inertia has delayed the implementation of these changes, which are vital to saving lives, reducing costs, and bringing life-saving treatments to patients more efficiently," ...
Recursion Pharmaceuticals, Inc. upgraded to Buy on promising REC-4881 data, strong partnerships, and AI-driven drug discovery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback